Citadel Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-547,822
| Closed | -$62K | – | 5338 |
|
|
2018
Q4 | $62K | Buy |
547,822
+510,182
| +1,355% | +$57.7K | ﹤0.01% | 4083 |
|
|
2018
Q3 | $64K | Buy |
+37,640
| New | +$64K | ﹤0.01% | 3975 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4802 |
|
|
2018
Q1 | – | Sell |
-263,448
| Closed | -$587K | – | 4659 |
|
|
2017
Q4 | $587K | Sell |
263,448
-5,863,884
| -96% | -$13.1M | ﹤0.01% | 2716 |
|
|
2017
Q3 | $17.8M | Buy |
6,127,332
+123,663
| +2% | +$359K | 0.01% | 697 |
|
|
2017
Q2 | $26.7M | Buy |
6,003,669
+94,203
| +2% | +$419K | 0.02% | 504 |
|
|
2017
Q1 | $27.5M | Buy |
5,909,466
+5,321,541
| +905% | +$24.8M | 0.03% | 474 |
|
|
2016
Q4 | $3.58M | Sell |
587,925
-1,203,170
| -67% | -$7.33M | ﹤0.01% | 1203 |
|
|
2016
Q3 | $9.87M | Buy |
1,791,095
+98,658
| +6% | +$544K | 0.01% | 775 |
|
|
2016
Q2 | $6.43M | Buy |
1,692,437
+1,139,087
| +206% | +$4.33M | 0.01% | 917 |
|
|
2016
Q1 | $1.53M | Sell |
553,350
-1,940,620
| -78% | -$5.36M | ﹤0.01% | 1580 |
|
|
2015
Q4 | $14.1M | Sell |
2,493,970
-1,420,685
| -36% | -$8.06M | 0.02% | 723 |
|
|
2015
Q3 | $20.7M | Buy |
3,914,655
+3,327,408
| +567% | +$17.6M | 0.02% | 624 |
|
|
2015
Q2 | $4.87M | Buy |
587,247
+538,674
| +1,109% | +$4.47M | ﹤0.01% | 1291 |
|
|
2015
Q1 | $224K | Buy |
48,573
+16,068
| +49% | +$74.1K | ﹤0.01% | 3061 |
|
|
2014
Q4 | $99K | Buy |
32,505
+13,447
| +71% | +$41K | ﹤0.01% | 3281 |
|
|
2014
Q3 | $53K | Buy |
19,058
+9,670
| +103% | +$26.9K | ﹤0.01% | 3167 |
|
|
2014
Q2 | $38K | Sell |
9,388
-29,369
| -76% | -$119K | ﹤0.01% | 3165 |
|
|
2014
Q1 | $206K | Buy |
+38,757
| New | +$206K | ﹤0.01% | 2826 |
|